Disparities in availability of new cancer drugs worldwide: 1990-2022
Introduction Despite progress in the development of new cancer drugs, concerns about equity of access remain. This study aimed to examine the availability and timeliness of availability of new cancer drugs around the globe over the past three decades and their associations with country characteristi...
Saved in:
| Main Authors: | Meng Li, Qiushi Chen, DukHee Ka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-10-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/9/9/e015700.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disparities in Cancer Mortality Worldwide: A Novel Metric for Measuring Global Disparities and Prioritizing Cancer Control Efforts
by: Thomas M. Diehl, et al.
Published: (2025-04-01) -
Worldwide Burden of Retinoblastoma from 1990 to 2021
by: Yaling Feng, et al.
Published: (2024-01-01) -
Comparative analysis of liver cancer burden trends in China and worldwide between 1990 and 2021
by: Chunrong Chen, et al.
Published: (2025-05-01) -
Regional disparities in the availability of cancer clinical trials in Korea
by: Jieun Jang, et al.
Published: (2023-12-01) -
Analysis of the mortality trends of laryngeal cancer attributable to smoking worldwide from 1990 to 2021 and projections up to 2036
by: Jie Yang, et al.
Published: (2025-06-01)